Furthermore, our findings of the ROC analysis demonstrated that soluble CXCL13 and soluble galectin-9 had very good specificity and sensitivity in detecting CLL disease progression. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.